Literature DB >> 30218158

Shigella and Enteroinvasive Escherichia Coli.

Ilia Belotserkovsky1, Philippe J Sansonetti2.   

Abstract

Shigella and enteroinvasive Escherichia coli (EIEC) are gram-negative bacteria responsible for bacillary dysentery (shigellosis) in humans, which is characterized by invasion and inflammatory destruction of the human colonic epithelium. Different EIEC and Shigella subgroups rose independently from commensal E. coli through patho-adaptive evolution that included loss of functional genes interfering with the virulence and/or with the intracellular lifestyle of the bacteria, as well as acquisition of genetic elements harboring virulence genes. Among the latter is the large virulence plasmid encoding for a type three secretion system (T3SS), which enables translocation of virulence proteins (effectors) from the bacterium directly into the host cell cytoplasm. These effectors enable the pathogen to subvert epithelial cell functions, promoting its own uptake, replication in the host cytosol, and dissemination to adjacent cells while concomitantly inhibiting pro-inflammatory cell death. Furthermore, T3SS effectors are directly involved in Shigella manipulation of immune cells causing their dysfunction and promoting cell death. In the current chapter, we first describe the evolution of the enteroinvasive pathovars and then summarize the overall knowledge concerning the pathogenesis of these bacteria, with a particular focus on Shigella flexneri. Subversion of host cell functions in the human gut, both epithelial and immune cells, by different virulence factors is especially highlighted.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30218158     DOI: 10.1007/82_2018_104

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  11 in total

1.  Infection with a human-derived enteroinvasive Escherichia coli strain altered intestinal barrier function in guinea pigs.

Authors:  Jian-Jun Liu; Juan-Juan Qiu; Xiu Shan; Xue-Qi Shang; Fu-Bo Sun; Ju-Ying Jiao; Ayaz Ahmed; Yi Xin; Dong Shang
Journal:  Int Microbiol       Date:  2022-06-20       Impact factor: 3.097

2.  Therapeutic Effect of Buyang Huanwu Decoction on the Gut Microbiota and Hippocampal Metabolism in a Rat Model of Cerebral Ischemia.

Authors:  Rongmei Tang; Jian Yi; Shuangying Lu; Bowei Chen; Baiyan Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-14       Impact factor: 6.073

Review 3.  Staying out or Going in? The Interplay between Type 3 and Type 5 Secretion Systems in Adhesion and Invasion of Enterobacterial Pathogens.

Authors:  Rachel Whelan; Gareth McVicker; Jack C Leo
Journal:  Int J Mol Sci       Date:  2020-06-08       Impact factor: 5.923

4.  Diallyl Disulfide (DADS) Ameliorates Intestinal Candida albicans Infection by Modulating the Gut microbiota and Metabolites and Providing Intestinal Protection in Mice.

Authors:  Wanchao Hu; Liou Huang; Ziyang Zhou; Liping Yin; Jianguo Tang
Journal:  Front Cell Infect Microbiol       Date:  2022-01-07       Impact factor: 5.293

5.  Effects of Three-Layer Encapsulated Tea Tree Oil on Growth Performance, Antioxidant Capacity, and Intestinal Microbiota of Weaned Pigs.

Authors:  Lixue Wang; Ying Zhang; Ling Liu; Fei Huang; Bing Dong
Journal:  Front Vet Sci       Date:  2021-12-02

6.  Gut metabolite Urolithin A mitigates ionizing radiation-induced intestinal damage.

Authors:  Yuanyang Zhang; Yinping Dong; Ping Lu; Xinyue Wang; Wenxuan Li; Hui Dong; Saijun Fan; Deguan Li
Journal:  J Cell Mol Med       Date:  2021-10-01       Impact factor: 5.310

Review 7.  The NEL Family of Bacterial E3 Ubiquitin Ligases.

Authors:  Andrea Bullones-Bolaños; Joaquín Bernal-Bayard; Francisco Ramos-Morales
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

8.  Microbial Profiles of Retail Pacific Oysters (Crassostrea gigas) From Guangdong Province, China.

Authors:  Mingjia Yu; Xiaobo Wang; Aixian Yan
Journal:  Front Microbiol       Date:  2021-07-07       Impact factor: 5.640

9.  Synthesis of Escherichia coli OmpA Oral Nanoparticles and Evaluation of Immune Functions against the Major Etiologic Agent of Cow Mastitis.

Authors:  Xiang Liu; Wei Sun; Nana Wu; Na Rong; Chao Kang; Sijie Jian; Chunlin Chen; Chen Chen; Xiaoying Zhang
Journal:  Vaccines (Basel)       Date:  2021-03-23

10.  Alterations in the gut microbiome and metabolome profiles of septic rats treated with aminophylline.

Authors:  Yuanzhe Li; Huayan Zhao; Guiying Sun; Yongtao Duan; Yanjun Guo; Lina Xie; Xianfei Ding
Journal:  J Transl Med       Date:  2022-02-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.